Show
Sort by
-
Disease outcomes and patient’s perspectives after switching biologics from intravenous to subcutaneous administration : a real-world experience in a tertiary IBD-unit
-
The comparative effectiveness and safety of different biologics in young (<60 years) versus elderly (≥60 years) patients with IBD : results from a real-world experience at a Belgian tertiary centre
-
Promising efficacy of biologicals and small molecules for microscopic colitis : results from a large real-life multicenter cohort
-
Age-related patterns in biological therapy use and surgery among patients with IBD : insights from the Belgian PANTHER cohort
-
Pre-operative exposure to tofacitinib is as safe as biologics in patients with ulcerative colitis undergoing colectomy : a multicentre observational study
-
- Journal Article
- A1
- open access
Noninvasive scores are poorly predictive of histological fibrosis in paediatric fatty liver disease
-
Machine learning improves prediction of postoperative outcomes after gastrointestinal surgery : a systematic review and meta-analysis
-
- Journal Article
- A1
- open access
Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections
-
- Journal Article
- A1
- open access
Reply : serotonin in gastrointestinal disorders : delineating peripheral versus central effects
-
Significant differences in IBD care and education across Europe : results of the pan-European VIPER survey